Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will take steps to ensure that people experiencing acute or chronic side effects from taking gabapentin do not have to wait for a (a) referral and (b) assessment by mental health services.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
While we have no specific plans to do so, we are committed to expanding and transforming mental health services in England through the NHS Long Term Plan, so that more people, including those experiencing side effects from taking gabapentin, can get the mental health help and support that they need.
Asked by: Catherine West (Labour - Hornsey and Wood Green)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what guidance her Department provides to NHS A&E departments to ensure staff are aware that A&E services are free of charge regardless of immigration status.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
The Department issues guidance to the National Health Service on charging overseas visitors for some NHS services. This guidance is reviewed regularly and makes it clear that some services, including accident and emergency, are free at the point of delivery for everyone. NHS England works with Overseas Visitor Managers in NHS trusts to operationalise this guidance effectively.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions she has had with community pharmacists on supporting people with (a) smoking and (b) vaping (i) addiction and (ii) dependency.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Quitting smoking is the best thing a smoker can do for their health and smokers are three times as likely to succeed with stop smoking services (SSS) when compared to an unsupported quit attempt. As announced in Stopping the start: our new plan to create a smokefree generation, published in October 2023, the Government is investing an additional £70 million per year for five years to support local authority-led SSS, around doubling current spend and supporting 360,000 people to set a quit date each year. Local authorities commission a variety of settings, including community pharmacy, to deliver SSS. In 2022/23, 12,165 of the 176,566 quit dates set through SSS were in a pharmacy setting. Since March 2022, hospitals have been referring patients to community pharmacy to continue the stop smoking journey they started in hospital as part of the NHS Smoking Cessation Service in community pharmacies agreed by the Department, NHS England and Community Pharmacy England. Across the country, 4841 community pharmacies have signed up to deliver the service.
In addition, we are establishing a financial incentives scheme to help pregnant smokers and their partners to quit smoking, with smoking cessation support. This evidence-based intervention will encourage pregnant women to give up smoking, and remain smokefree throughout pregnancy and beyond, helping to improve the health and wellbeing of both mother and baby.
Asked by: Lord Hunt of Kings Heath (Labour - Life peer)
Question to the Department for Levelling Up, Housing & Communities:
To ask His Majesty's Government how they plan to reduce the rates of deaths of despair in the North East, which has over double the rate of London; and what assessment they have made of using rates of deaths of despair to assess progress on levelling up.
Answered by Baroness Swinburne - Parliamentary Under Secretary of State (Department for Levelling Up, Housing and Communities)
The Supplemental Substance Misuse Treatment and Recovery (SSMTR) Grant is the mechanism by which local authorities receive Drug Strategy funding to increase substance misuse treatment service capacity and the quality of interventions people receive. The SSMTR Grant is made available to local authorities on the condition of maintaining existing funding through the Public Health Grant.
Details of the SSMTR Grant and the Inpatient Detox (IPD) Grant allocations for the North East are set out below.
| 2022-23 | 2023-24 | 2024-25 | 2022-23 to 2024-25 |
SSMTR | £7,051,992 | £13,677,970 | £24,787,253 | £45,517,215 |
IPD | £727,295 | £727,295 | £727,295 | £2,181,885 |
DHSC is also providing £1,157,212 in funding to three local authorities in the North East (Middlesborough, Newcastle and Durham) to improve access to drug and alcohol treatment services for people who sleep rough or who are at risk of sleeping rough.
On 11 September 2023, the Government published a Suicide Prevention Strategy for England, with over 130 actions that we believe will make progress towards our ambition to reduce the suicide rate within two and a half years. The Strategy includes an intention to write guidance for local areas to support them to align their own strategies with the national strategy.
On 4 March 2024, we announced that 79 organisations up and down the country, including some in the North East, have been allocated funding from the £10 million Suicide Prevention VCSE Grant Fund. These organisations, from local, community-led through to national, are delivering a broad and diverse range of activity that will prevent suicides and save lives.
The Levelling Up White Paper set out 12 missions, including the health mission, focused on improving Healthy Life Expectancy and narrowing the gap between local areas where it is highest and lowest.
We are supporting people to live healthier lives, helping the NHS and social care to provide the best treatment and care for patients and tackling health disparities through national and system interventions such as the NHS’s Core20PLUS5 programme.
We are monitoring progress on a range of behavioural risk factors and underlying drivers of health, which are likely to impact on the health mission. We continue to use metrics that are publicly available and routinely updated to measure the levelling up missions, chosen to show as comprehensive a picture across the UK as possible. We are committed to developing this data picture and improving understanding of health disparities at a local level.
Asked by: Christopher Chope (Conservative - Christchurch)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much the administration of the Vaccine Damage Payment Scheme cost the NHS Business Services Authority in (a) 2021, (b) 2022 and (c) 2023.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The NHS Business Services Authority (NHSBSA) administers the Vaccine Damage Payment Scheme, on behalf of the Department. Administration costs for the scheme were £600,000, £8.8 million, and £16.1 million for April 2021 to March 2022, April 2022 to March 2023, and April 2023 to March 2024, respectively. Payments made by the NHSBSA for the provision of medical records totalled £1,200, £72,000, and £73,100, for the same periods. The figures are provided to the nearest decimal place.
Asked by: Theresa Villiers (Conservative - Chipping Barnet)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions she has had with NHS England on progress on improving outcomes for patients suffering from pancreatic cancer.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Tackling cancer is a key priority for the Government. Ministers and officials continue to work closely with NHS England to increase positive outcomes for all cancer types, including pancreatic cancer. The National Health Service is delivering a range of interventions expected to increase early diagnosis and improve outcomes for those with pancreatic cancer. This includes: providing a route into pancreatic cancer surveillance for those at inherited high-risk, to identify lesions before they develop into cancer, and diagnose cancers sooner; creating new pathways to support faster referral routes for people with non-specific symptoms that could be linked to a range of cancer types; and increasing direct access for general practitioners to arrange diagnostic tests.
NHS England is also funding a new audit into pancreatic cancer to increase the consistency of access to treatments, and to stimulate improvements in cancer treatment and outcomes. The Royal College of Surgeons began work on this audit in October 2022, and the first report is expected in October 2024. In addition to this, the Getting it Right First Time team in NHS England is undertaking a deep dive into pancreatic cancer, which will highlight actions NHS providers need to take to improve services, as well as gathering examples of good practice to share.
The NHS is working towards its Long Term Plan ambition of diagnosing 75% of stageable cancers at stage one and two by 2028. Achieving this will mean that an additional 55,000 people each year will survive their cancer for at least five years after diagnosis. With progress made on reducing waiting times, cancer is being diagnosed at an earlier stage more often, with survival rates improving across almost all types of cancer.
Asked by: Caroline Nokes (Conservative - Romsey and Southampton North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much her Department spent on autism assessments in each of the last five years; how much funding her Department has allocated to autism assessments in each of the next three years; and what recent assessment her Department has made of the adequacy of that funding in meeting the target waiting time for such an assessment.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Information on the total spend on autism assessments is not held centrally. NHS England is responsible for funding allocations to integrated care boards (ICBs), which are responsible for commissioning services using these core allocations to meet the needs of their local populations, including autism assessment services. The following table shows the total baseline expenditure in ICBs for learning disability and autism services over the last five years, disaggregated for autism services where possible:
| Learning disability | Autism services | Unseparated learning disability and autism services | Total |
2019/20 | N/A | N/A | £1,809,200,000 | £1,809,200,000 |
2020/21 | N/A | N/A | £2,285,600,000 | £2,285,600,000 |
2021/22 | £85,800,000 | £3,700,000 | £2,268,300,000 | £2,357,900,000 |
2022/23 | £625,800,000 | £27,100,000 | £1,928,800,000 | £2,581,700,000 |
2023/24 | £926,000,000 | £47,100,000 | £1,928,800,000 | £2,904,600,000 |
In addition, specific funding has been allocated to ICBs in 2023/4 and 2024/25 from the Service Development Funding, to improve autism assessment waiting lists and pathways. The following table shows information on the additional national funding allocated to ICBs by NHS England, over each of the last five years, to improve autism assessment waiting lists and pathways:
| Service Development Funding via the NHS Long Term Plan Transformation Funding | Spending Review 2021 via the COVID-19 Recovery Fund | Total funding for autism assessment pathways |
2019/20 | N/A | N/A | N/A |
2020/21 | N/A | N/A | N/A |
2021/22 | £2,500,000 | £14,500,000 | £17,000,000 |
2022/23 | £5,000,000 | N/A | £5,000,000 |
2023/24 | £4,200,000 | N/A | £4,200,000 |
2024/25 | £4,300,000 | N/A | £4,300,000 |
Notes:
The NHS Operational and Planning Guidance 2024/25 asks local systems to improve autism assessment pathways, through implementation of the NHS England autism assessment national framework. Allocations from 2025/26 onwards are subject to future decisions on spending. Further information on the operational and planning guidance and national framework is available respectively at the following links:
https://www.england.nhs.uk/publication/autism-diagnosis-and-operational-guidance/
A specific assessment of the adequacy of funding in meeting the National Institute for Health and Care Excellence’s waiting time standard for autism assessments has not been made. However, autism waiting times statistics are published on a quarterly basis. The total number of people with an open referral, where the diagnosis not yet completed, for suspected autism has increased by 47%, from 117,032 in December 2022 to 172,022 in December 2023. In December 2023, it was estimated that only 5.9% of patients whose referrals have been open in the system for at least 13 weeks received their first contact appointment within 13 weeks.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make it her policy to require an independent second assessment prior to discharging a person from mental health services.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
On 26 January 2024, new statutory guidance was published for those being discharged from mental health inpatient settings. This sets out how health and care systems can work together effectively to support the discharge process from all mental health inpatient settings, and ensure the right support in the community. The guidance also includes best practice on how patients and carers should be involved in discharge planning. There are currently no plans to update this guidance covering the process for discharge.
The Mental Health Act Code of Practice provides statutory guidance on the care and treatment of patients detained under the Mental Health Act, including consideration of whether someone is ready to be discharged, and who should be involved in making this decision.
As part of its planning guidance, NHS England has asked all local systems to review their community mental health services to ensure that they have clear policies and practice in place for patients with serious mental illness, who require intensive community treatment and follow-up, but where engagement is a challenge. NHS England plans to provide national guidance by Autumn 2024, to support these reviews. NHS England will consider further steps as appropriate, following the completion of the reviews.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that mental health discharge processes protect the (a) patient and (b) community.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
On 26 January 2024, new statutory guidance was published for those being discharged from mental health inpatient settings. This sets out how health and care systems can work together effectively to support the discharge process from all mental health inpatient settings, and ensure the right support in the community. The guidance also includes best practice on how patients and carers should be involved in discharge planning. There are currently no plans to update this guidance covering the process for discharge.
The Mental Health Act Code of Practice provides statutory guidance on the care and treatment of patients detained under the Mental Health Act, including consideration of whether someone is ready to be discharged, and who should be involved in making this decision.
As part of its planning guidance, NHS England has asked all local systems to review their community mental health services to ensure that they have clear policies and practice in place for patients with serious mental illness, who require intensive community treatment and follow-up, but where engagement is a challenge. NHS England plans to provide national guidance by Autumn 2024, to support these reviews. NHS England will consider further steps as appropriate, following the completion of the reviews.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she is taking steps to ensure that family hubs provide advice on smoking and vaping harm reduction.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Smoking is the number one entirely preventable cause of ill-health, disability, and death in this country. It is responsible for 80,000 yearly deaths in the United Kingdom, and one in four of all UK cancer deaths. It costs our country £17 billion a year, £14 billion of which is through lost productivity alone. It puts a huge pressure on the National Health Service and social care, costing over £3 billion a year.
The Government is investing an additional £300 million to improve support for families, though the joint Department of Health and Social Care and Department for Education Family Hubs and Start for Life programme. The Family Hubs and Start for Life programme guide sets out minimum expectations that local authorities receiving programme funding should deliver by March 2025. With regards to smoking support, the programme guide sets out that staff in a family hub are expected to be trained in delivering Very Brief Advice on smoking to parents identified as smokers, and some family hubs may provide smoking cessation support on-site, for example through drop-ins.
Staff in family hubs know what stop smoking services (SSS) are provided locally, and connect families to these services. Smokers are three times as likely to succeed with SSS, when compared to an unsupported quit attempt. As announced in Stopping the start: our new plan to create a smokefree generation, published in October 2023, the Government is investing an additional £70 million per year, for five years, to support local authority led SSS, almost doubling current spend and supporting 360,000 people to set a quit date each year.
In addition, we are establishing a financial incentives scheme to help pregnant smokers and their partners to quit smoking, with smoking cessation support. This evidence-based intervention will encourage pregnant women to give up smoking, and remain smokefree throughout pregnancy and beyond, helping to improve the health and wellbeing of both mother and baby.
Whilst anyone smoking should focus on giving up cigarettes before giving up vaping, giving up vaping is an important step in overcoming nicotine dependence. We are working with the NHS Better Health website to provide advice for people who want to quit vaping. The National Centre for Smoking Cessation and Training has produced guidance for local SSS staff, on how best to support vapers to quit. We are also exploring further ways to support people to quit vaping, as part of the national Swap to Stop programme.